142 related articles for article (PubMed ID: 11802199)
21. Combination of p53 expression and p21 loss has an independent prognostic impact on sporadic colorectal cancer.
Noske A; Lipka S; Budczies J; Müller K; Loddenkemper C; Buhr HJ; Kruschewski M
Oncol Rep; 2009 Jul; 22(1):3-9. PubMed ID: 19513497
[TBL] [Abstract][Full Text] [Related]
22. Determination of molecular marker expression can predict clinical outcome in colon carcinomas.
Galizia G; Lieto E; Ferraraccio F; Orditura M; De Vita F; Castellano P; Imperatore V; Romano C; Ciardiello F; Agostini B; Pignatelli C
Clin Cancer Res; 2004 May; 10(10):3490-9. PubMed ID: 15161706
[TBL] [Abstract][Full Text] [Related]
23. Correlation of N-myc downstream-regulated gene 1 expression with clinical outcomes of colorectal cancer patients of different race/ethnicity.
Koshiji M; Kumamoto K; Morimura K; Utsumi Y; Aizawa M; Hoshino M; Ohki S; Takenoshita S; Costa M; Commes T; Piquemal D; Harris CC; Tchou-Wong KM
World J Gastroenterol; 2007 May; 13(20):2803-10. PubMed ID: 17569115
[TBL] [Abstract][Full Text] [Related]
24. Tissue microarray molecular profiling of early, node-negative adenocarcinoma of the rectum: a comprehensive analysis.
Hoos A; Nissan A; Stojadinovic A; Shia J; Hedvat CV; Leung DH; Paty PB; Klimstra D; Cordon-Cardo C; Wong WD
Clin Cancer Res; 2002 Dec; 8(12):3841-9. PubMed ID: 12473598
[TBL] [Abstract][Full Text] [Related]
25. Re: loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer.
Manne U; Myers RB; Srivastava S; Grizzle WE
J Natl Cancer Inst; 1997 Apr; 89(8):585-6. PubMed ID: 9106651
[No Abstract] [Full Text] [Related]
26. P53 overexpression predicts poor chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV colorectal cancers after palliative bowel resection.
Liang JT; Huang KC; Cheng YM; Hsu HC; Cheng AL; Hsu CH; Yeh KH; Wang SM; Chang KJ
Int J Cancer; 2002 Feb; 97(4):451-7. PubMed ID: 11802206
[TBL] [Abstract][Full Text] [Related]
27. Molecular characterization of colorectal neoplasia in translational research.
Grizzle WE; Manne U; Jhala NC; Weiss HL
Arch Pathol Lab Med; 2001 Jan; 125(1):91-8. PubMed ID: 11151060
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of BMP and activin membrane-bound inhibitor in colorectal cancer.
Togo N; Ohwada S; Sakurai S; Toya H; Sakamoto I; Yamada T; Nakano T; Muroya K; Takeyoshi I; Nakajima T; Sekiya T; Yamazumi Y; Nakamura T; Akiyama T
World J Gastroenterol; 2008 Aug; 14(31):4880-8. PubMed ID: 18756595
[TBL] [Abstract][Full Text] [Related]
29. Are clinicopathological features of colorectal cancers with methylation in half of CpG island methylator phenotype panel markers different from those of CpG island methylator phenotype-high colorectal cancers?
Bae JM; Rhee YY; Kim KJ; Wen X; Song YS; Cho NY; Kim JH; Kang GH
Hum Pathol; 2016 Jan; 47(1):85-94. PubMed ID: 26520418
[TBL] [Abstract][Full Text] [Related]
30. Bcl-2 expression and response to chemotherapy in colorectal adenocarcinomas.
Schneider HJ; Sampson SA; Cunningham D; Norman AR; Andreyev HJ; Tilsed JV; Clarke PA
Br J Cancer; 1997; 75(3):427-31. PubMed ID: 9020491
[TBL] [Abstract][Full Text] [Related]
31. Immunoexpression of TS, p53, COX2, EGFR, MSH6 and MLH1 biomarkers and its correlation with degree of differentiation, tumor staging and prognostic factors in colorectal adenocarcinoma: a retrospective longitudinal study.
Batista WR; Santos G; Vital FMR; Matos D
Sao Paulo Med J; 2019 May; 137(1):33-38. PubMed ID: 31116268
[TBL] [Abstract][Full Text] [Related]
32. Micropapillary component in colorectal carcinoma is associated with lymph node metastasis in T1 and T2 Stages and decreased survival time in TNM stages I and II.
Xu F; Xu J; Lou Z; Di M; Wang F; Hu H; Lai M
Am J Surg Pathol; 2009 Sep; 33(9):1287-92. PubMed ID: 19471152
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of cell cycle and apoptosis regulatory proteins in mismatch repair-proficient colorectal cancer: a tissue microarray-based approach.
Tornillo L; Lugli A; Zlobec I; Willi N; Glatz K; Lehmann F; Spichtin HP; Maurer R; Stoios D; Sauter G; Terracciano L
Am J Clin Pathol; 2007 Jan; 127(1):114-23. PubMed ID: 17145638
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of p53 codon 72 polymorphism differs with race in colorectal adenocarcinoma.
Katkoori VR; Jia X; Shanmugam C; Wan W; Meleth S; Bumpers H; Grizzle WE; Manne U
Clin Cancer Res; 2009 Apr; 15(7):2406-16. PubMed ID: 19339276
[TBL] [Abstract][Full Text] [Related]
35. Cytoplasmic localization of p27 (cyclin-dependent kinase inhibitor 1B/KIP1) in colorectal cancer: inverse correlations with nuclear p27 loss, microsatellite instability, and CpG island methylator phenotype.
Ogino S; Kawasaki T; Ogawa A; Kirkner GJ; Loda M; Fuchs CS
Hum Pathol; 2007 Apr; 38(4):585-92. PubMed ID: 17239930
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical expression of bcl-2 in UICC stage I and III colorectal carcinoma patients: correlation with c-erbB-2, p53, ki-67, CD44, laminin and collagen IV in evaluating prognostic significance.
Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
Pol J Pathol; 2006; 57(3):149-59. PubMed ID: 17219742
[TBL] [Abstract][Full Text] [Related]
37. Expression of SGLT1, Bcl-2 and p53 in primary pancreatic cancer related to survival.
Casneuf VF; Fonteyne P; Van Damme N; Demetter P; Pauwels P; de Hemptinne B; De Vos M; Van de Wiele C; Peeters M
Cancer Invest; 2008 Oct; 26(8):852-9. PubMed ID: 18853313
[TBL] [Abstract][Full Text] [Related]
38. Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer.
Smith RA; Tang J; Tudur-Smith C; Neoptolemos JP; Ghaneh P
Br J Cancer; 2011 Apr; 104(9):1440-51. PubMed ID: 21448172
[TBL] [Abstract][Full Text] [Related]
39. Does biomolecular characterization of stage II/III colorectal cancer have any prognostic value?
Funaioli C; Pinto C; Mutri V; Di Fabio F; Ceccarelli C; Martoni AA
Clin Colorectal Cancer; 2006 May; 6(1):38-45. PubMed ID: 16796790
[TBL] [Abstract][Full Text] [Related]
40. Clinical relevance of transforming growth factor alpha, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors.
De Jong KP; Stellema R; Karrenbeld A; Koudstaal J; Gouw AS; Sluiter WJ; Peeters PM; Slooff MJ; De Vries EG
Hepatology; 1998 Oct; 28(4):971-9. PubMed ID: 9755233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]